Preview

Meditsinskiy sovet = Medical Council

Advanced search

Pharmacotherapy of cystic fibrosis: inhaled antibiotics

https://doi.org/10.21518/2079-701X-2013-11-62-69

Abstract

Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in shaping the prognosis of the disease. Microbiology of respiratory infection in such patients is significantly different from that in patients without cystic fibrosis. Adequate antibiotic therapy with inhaled drugs can delay and sometimes even prevent the onset of chronic Pseudomonas aeruginosa infection, while significantly extending the years of qualitative life of patients with cystic fibrosis.

About the Author

N. I. Kapranov
Research Centre of Medical Genetics of RAMS
Russian Federation


References

1. Капранов Н.И., Каширская Н.Ю., Шерман В.Д. и др. Муковисцидоз. Современные достижения и

2. актуальные проблемы: Методические рекомендации. М., 2011.

3. Никонова В.С., Капранов Н.И., Кондратьева Е.И., Шерман В.Д., Каширская Н.Ю. и др.: Сборник

4. тезисов ХI Национального конгресса. Микробиологический мониторинг флоры дыхательных

5. путей детей, больных муковисцидозом, наблюдающихся в московском отделении российского

6. центра муковисцидоза.

7. Hofmann T. // Curr. Pharm. Des. 2012. V. 18. №5. P. 683.

8. Чикина С.Ю. // Лечебное дело. 2011. №4. С. 105.

9. Ballman M. et al. // Respir. Med. 2011. V. 105. Suppl. 2. P. S2.

10. Gibson R.L. et al. // Pediatr. Pulmonol. 2007. V. 42. P. 610.

11. Sawicki G.S. et al. // Pediatr. Pulmonol. 2012. V. 47. №1. P. 44.

12. Heijerman H.G. et al. // J. Cyst. Fibros. V. 8. №5. P. 295.

13. Chuchalin A., Amelina E., Bianco F. Tobramycin for inhalation in cystic fibrosis: Beyond respiratory

14. improvements // Pulm. Pharmacol. Ther. 2009. №22(6). P. 526–32. doi: 1016/j.pupt.2009.06.001.

15. Epub. 2009. Jul 16.

16. Chuchalin A., Csiszér E., Gyurkovics K., Bartnicka M.T., Sands D., Kapranov N., Varoli G., Monici Preti

17. P.A., Mazurek H. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with

18. cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter

19. study // Paediatr. Drugs. 2007. №9. Suppl 1. P. 21–31.

20. Poli G., Acerbi D., Pennini R., Soliani Raschini A., Corrado M.E., Eichler H.G., Eichler I. Clinical pharmacology

21. study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi // Paediatr.

22. Drugs. 2007. №9. Suppl 1. P. 3–9.

23. Konstan M.W. et al. // J. Cyst. Fibros. 2011. V. 10. №1. P. 54.

24. Konstan M.W. et al. // Pediatr. Pulmonol. 2011. V. 46. №3. P. 230.


Review

For citations:


Kapranov NI. Pharmacotherapy of cystic fibrosis: inhaled antibiotics. Meditsinskiy sovet = Medical Council. 2013;(11):62-69. (In Russ.) https://doi.org/10.21518/2079-701X-2013-11-62-69

Views: 399


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)